Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers look for ’silenced’ genes to monitor kidney cancer patients

19.04.2005


Researchers at Fox Chase Cancer Center in Philadelphia say looking for genes that have been turned off by cancer cells may become a reliable and noninvasive way to detect and monitor cancer in the kidney. The data were presented today at the 96th Annual Meeting of the American Association for Cancer Research in Anaheim, Calif.



Tumor-suppressor genes are part of the body’s natural defense against cancer. When inactivated--or "silenced"--they can no longer do their job, allowing cancer cells to grow. Cancer cells use a mechanism called hypermethylation to turn off the tumor-suppressor genes. "Finding these ’silenced’ genes is a good way to find cancer," said Essel A. Dulaimi, M.D., a postdoctoral fellow at Fox Chase. "Abnormal patterns of methylation can be detected in many cancers, including kidney cancer," she added. Early diagnosis of kidney cancer can lead to earlier treatment with a curative outcome.

Dulaimi and fellow Fox Chase researchers used a molecular DNA-based test to determine the presence or absence of methylation in a particular gene. Called methylation-specific polymerase chain reaction (PCR), the test can find one methylated gene among 100 unmethylated alleles (genes at the same site on a specific chromosome).


"This specificity is enough to detect even a few cancer cells among healthy cells," explained molecular biologist Paul Cairns, Ph.D., lead researcher of the study.

In an earlier Fox Chase study with six methylated genes (Cancer Research, Dec. 15, 2003), Dulaimi, Cairns, urologic surgical oncologist Robert G. Uzzo, M.D., and colleagues found an identical pattern of hypermethylation in both kidney tumors and urine collected before surgery. Forty-four of 50 urine samples (88 percent specificity) had a methylation pattern identical to the original tumor; all of the healthy patients showed no methylation (100 percent specificity).

"A gene that was postive for methylation in the urine was always positive in the matched tumor, " explained Cairns. "This is important because the DNA can be studied in the urine samples of patients who are being followed up after kidney surgery."

Thus, the methylation-specific test is a useful noninvasive tool. Until now, renal cancer could only be identified by a pathologist reviewing tumor tissue. In the study presented today at AACR, the researchers tested samples from 25 patients aged 33 to 73 who had undergone surgery to remove cancerous tumors confined to the kidney. At follow-up after surgery, none of the 25 patients had clinical evidence of disease.

The researchers hypothesized that these patients--who earlier had methylated tumors but now had no clinical evidence of disease--would have a follow-up urine sample that would show no methylation. This would confirm that they were, in fact, clinically disease-free.

The results showed that two patients had the same methylated gene in their urine samples that was methylated in the tumor. The other 23 patients had unmethylated genes in their urine samples.

"This means that we can monitor the presence of cancer by checking DNA in the urine periodically and looking for hypermethylation," said Uzzo.

"Our studies have proved that looking for hypermethylation in specific tumor-suppressor genes is useful for finding kidney cancer," Cairns said. "Now, it can also be applied to clinical follow up for patients with renal cancer."

Colleen Kirsch | EurekAlert!
Further information:
http://www.fccc.edu

More articles from Life Sciences:

nachricht Nanoparticle Exposure Can Awaken Dormant Viruses in the Lungs
16.01.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Cholera bacteria infect more effectively with a simple twist of shape
13.01.2017 | Princeton University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Water - as the underlying driver of the Earth’s carbon cycle

17.01.2017 | Earth Sciences

Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

17.01.2017 | Materials Sciences

Smart homes will “LISTEN” to your voice

17.01.2017 | Architecture and Construction

VideoLinks
B2B-VideoLinks
More VideoLinks >>>